Is ORASURE TECHNOLOGIES INC (OSUR) Halal?
Shariah Screening — 5 Standards
Based on financial data from December 2025
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 6.3% / 30% | 114.8% / 30% | 10.2% / 30% | 4.23% / 5% | ✗ NOT HALAL |
| DJIM | 6.3% / 33% | 114.8% / 33% | 10.2% / 33% | 4.23% / 5% | ✗ NOT HALAL |
| MSCI | 3.0% / 33% | 55.8% / 33% | 5.0% / 33% | 4.23% / 5% | ✗ NOT HALAL |
| S&P | 6.3% / 33% | 114.8% / 33% | 10.2% / 33% | 4.23% / 5% | ✗ NOT HALAL |
| FTSE | 3.0% / 33% | 55.8% / 33% | 5.0% / 50% | 4.23% / 5% | ✗ NOT HALAL |
Financial Highlights
Profitability
| Gross Margin | 41.9% | |
| Operating Margin | -61.1% | |
| Net Margin | -59.8% | |
| Return on Equity (ROE) | -18.3% | |
| Return on Assets (ROA) | -9.6% |
Cash Flow & Balance Sheet
| Operating Cash Flow | -$49M |
| Free Cash Flow | -$53M |
| Total Debt | $13M |
| Debt-to-Equity | 3.9 |
| Current Ratio | 6.6 |
| Total Assets | $403M |
Price & Trading
| Last Close | $3.07 |
| 50-Day MA | $2.89 |
| 200-Day MA | $2.88 |
| Avg Volume | 547K |
| Beta | 0.9 |
|
52-Week Range
$2.08
| |
About ORASURE TECHNOLOGIES INC (OSUR)
OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, sells, and distributes diagnostic products and specimen collection devices in the United States, Europe, Africa, and internationally. It offers OraQuick Rapid HIV test, OraQuick HIV self-test, OraQuick HIV self-test(international), OraQuick HCV rapid antibody test and self-test, Syphilis health check rapid diagnostic test, OraQuick Ebola rapid antigen test, InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid test pro, InteliSwab COVID-19 rapid test rx, SickleSCAN test, and OraSure oral fluid collection device for HIV-1 antibodies; Intercept drug testing systems; immunoassay tests and reagents; and Q.E.D. saliva alcohol test. The company also provides genomic products under the Oragene and ORAcollect brands for collecting genetic material from human saliva; Colli-Pee collection devices for the volumetric collection of urine samples; and HEMAcollect protein blood collection device. In addition, it provides microbiome products, such as OMNIgene GUT for self-collecting microbial DNA from feces or stool samples for gut microbiome profiling; OMNIgene GUT DNA and RNA collection devices; OMNIgene SALIVA DNA and RNA collection devices; and OMNIgene GUT Dx collection device for collection of human fecal samples and the stabilization of DNA from the bacterial community. Further, it offers other diagnostic products, such as immunoassays and other in vitro diagnostic tests. Additionally, it develops a molecular self-test for chlamydia trachomatis and neisseria gonorrhoeae. It sells its products to clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, commercial and industrial entities, disease risk management, diagnostics, pharmaceutical, biotech, and companion animal, markets. The company was founded in 1987 and is headquartered in Bethlehem, Pennsylvania.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is ORASURE TECHNOLOGIES INC (OSUR) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), ORASURE TECHNOLOGIES INC is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is ORASURE TECHNOLOGIES INC's debt ratio?
ORASURE TECHNOLOGIES INC's debt ratio is 6.3% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 3.0%.
What are ORASURE TECHNOLOGIES INC's key financial metrics?
ORASURE TECHNOLOGIES INC has a market capitalization of $207M, and revenue of $115M. The company maintains a gross margin of 41.9% and a net margin of -59.8%. Return on equity stands at -18.3%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.